About DiagnoVie
DiagnoVie is a Healthcare company based in Ronchin (France) founded in 2018, and was acquired by Biogroup LCD in May 2022. Pathology laboratory services are provided through a chain in France. DiagnoVie offers products and services including Medical Analyses, Covid-19 Testing, and Genetics Services. Its focus areas include Clinical Laboratory Chains and Pathology.
Company details
DiagnoVie was founded in 2018 and is headquartered in Ronchin, France. Operations focus on the healthcare sector, specifically pathology diagnostics. A network of laboratories is maintained to deliver testing and analysis services for medical samples. Coverage extends across regional facilities in France, supporting clinical pathology needs for healthcare providers and patients. The domain diagnovie.fr is used for online access to services and information.
- Headquarters Ronchin, France
- Stage Acquired
- SectorsHealthcare
- Website diagnovie.fr
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Biogroup LCD (May 2022)
- Investors
- Acquired byBiogroup LCD
(May 2022)
Products & Services of DiagnoVie
DiagnoVie offers a comprehensive portfolio of products and services, including Medical Analyses, Covid-19 Testing, and Genetics Services.
Provides testing for biological samples and results access
Offers screening and diagnostics for Covid-19 infections
Conducts genetic testing and related analyses
Apps and channels of DiagnoVie
its YouTube channel BIOGROUP has 1.22K subscribers and 24 videos.
Videos from DiagnoVie
The most watched videos on DiagnoVie's YouTube channel, BIOGROUP (1.22K subscribers). Click a video to play it here.
More on BIOGROUP.
Investors in DiagnoVie
DiagnoVie has secured backing from 1 investor. Prominent investors backing the company include Biogroup.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biological analyses are conducted by a network of medical laboratories. | 1998 | biogroup.fr | Paris, France |
Investor details for DiagnoVie
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of DiagnoVie
2 dated milestones of DiagnoVie across 4 years, from founding to its latest funding, stage changes and deals.
- Founded DiagnoVie is founded.
- Exit Acquired by Biogroup LCD.
Web traffic of DiagnoVie
The website of DiagnoVie (diagnovie.fr) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 11.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DiagnoVie
DiagnoVie was founded in 2018.
DiagnoVie is headquartered in Ronchin, France. It is registered at Ronchin, Hauts-de-france, France.
DiagnoVie was founded in 2018 and is headquartered in Ronchin, France. Operations focus on the healthcare sector, specifically pathology diagnostics. A network of laboratories is maintained to deliver testing and analysis services for medical samples. Coverage extends across regional facilities in France, supporting clinical pathology needs for healthcare providers and patients. The domain diagnovie.fr is used for online access to services and information.
DiagnoVie offers Medical Analyses, Covid-19 Testing, and Genetics Services.
DiagnoVie has 1 investor. Key investors include Biogroup.
Yes. DiagnoVie was acquired by Biogroup LCD in May 2022.